NCT01257841View on ClinicalTrials.gov

Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

Leptin administration

Leptin 0.05 mg/kg sc daily in divided doses (0800, 1400, 2000, and 0200h) for four days.

BEHAVIORAL

Fasting

Complete fasting, save for water and multivitamin, for four days.

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02139

Massachusetts Institute of Technology, Cambridge

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01257841 - Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects | Biotech Hunter | Biotech Hunter